Á lódáil...
SUN-418 An Uncommon Case of Anti-PD1 Agent Induced Secondary Adrenal Insufficiency
Introduction - Nivolumab is a monoclonal anti-programmed cell death receptor 1(PD1) antibody approved for the treatment of unresectable or metastatic melanoma and is known to be associated with a wide spectrum of endocrinologic derangements. The objective of this report is to describe a case of symp...
Na minha lista:
| Foilsithe in: | J Endocr Soc |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Endocrine Society
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553168/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-418 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|